SJS Investment Consulting’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ECSS
CIM
ATO
SJS Investment Consulting's GILD Position: Q2 2026 in Review
SJS Investment Consulting increased its Gilead Sciences (GILD) stake by 0.29% in Q2 2026, buying an estimated $264 and bringing the position to 681 shares worth $86K. The position accounts for 0.01% of the portfolio, ranked #271.
SJS Investment Consulting first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $94.6K in Q1 2026. 853 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- SJS Investment Consulting held 681 shares of Gilead Sciences worth $86K as of Q2 2026.
- SJS Investment Consulting bought 2 Gilead Sciences shares in Q2 2026, an estimated $264.
- Gilead Sciences made up 0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #271 holding.
- SJS Investment Consulting first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- SJS Investment Consulting's Gilead Sciences position peaked at $94.6K in Q1 2026.
- 853 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.